Literature DB >> 11094007

The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury.

P J Siddall1, A R Molloy, S Walker, L E Mather, S B Rutkowski, M J Cousins.   

Abstract

We performed a double-blinded, randomized, controlled trial in 15 patients to determine the efficacy of intrathecal morphine or clonidine, alone or combined, in the treatment of neuropathic pain after spinal cord injury. The combination of morphine and clonidine produced significantly more pain relief than placebo 4 h after administration; either morphine or clonidine alone did not produce as much pain relief. In addition, lumbar and cervical cerebrospinal fluid (CSF) concentrations, sampled at these levels at different times after administration were examined for a relationship between pain relief and CSF drug concentration. Lumbar CSF drug concentrations were initially several orders of magnitude larger than those in cervical CSF. After 1-2 h, the concentrations of morphine in cervical CSF markedly exceeded those of clonidine. The concentration of morphine in the cervical CSF and the degree of pain relief correlated significantly. We conclude that intrathecal administration of a mixture of clonidine and morphine is more effective than either drug administered alone and is related to the CSF-borne drug concentration above the level of spinal cord injury. If there is pathology that may restrict CSF flow, consideration should be given to intrathecal administration above the level of spinal cord damage to provide an adequate drug concentration in this region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094007     DOI: 10.1097/00000539-200012000-00037

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  36 in total

Review 1.  Combination pharmacotherapy for the treatment of neuropathic pain in adults.

Authors:  Luis Enrique Chaparro; Philip J Wiffen; R Andrew Moore; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

2.  Effect of the Combination of CI-988 and Morphine on Neuropathic Pain after Spinal Cord Injury in Rats.

Authors:  Junesun Kim; Youngkyung Kim; Suk-Chan Hahm; Young Wook Yoon
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

Review 3.  New Cancer Pain Treatment Options.

Authors:  Kenneth D Candido; Teresa M Kusper; Nebojsa Nick Knezevic
Journal:  Curr Pain Headache Rep       Date:  2017-02

4.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

Review 5.  A systematic review of pharmacologic treatments of pain after spinal cord injury.

Authors:  Robert W Teasell; Swati Mehta; Jo-Anne L Aubut; Brianne Foulon; Dalton L Wolfe; Jane T C Hsieh; Andrea F Townson; Christine Short
Journal:  Arch Phys Med Rehabil       Date:  2010-05       Impact factor: 3.966

Review 6.  Intrathecal drug delivery for chronic pain management-scope, limitations and future.

Authors:  M Czernicki; G Sinovich; I Mihaylov; B Nejad; S Kunnumpurath; G Kodumudi; N Vadivelu
Journal:  J Clin Monit Comput       Date:  2014-08-31       Impact factor: 2.502

Review 7.  Analgesic synergy between opioid and α2 -adrenoceptors.

Authors:  A-J Chabot-Doré; D J Schuster; L S Stone; G L Wilcox
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 8.  Evaluation and Management of SCI-Associated Pain.

Authors:  Michael Saulino; Justin F Averna
Journal:  Curr Pain Headache Rep       Date:  2016-09

Review 9.  Morphine for chronic neuropathic pain in adults.

Authors:  Tess E Cooper; Junqiao Chen; Philip J Wiffen; Sheena Derry; Daniel B Carr; Dominic Aldington; Peter Cole; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-05-22

10.  Chronic at- and below-level pain after moderate unilateral cervical spinal cord contusion in rats.

Authors:  Megan Ryan Detloff; Rodel E Wade; John D Houlé
Journal:  J Neurotrauma       Date:  2013-05-15       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.